Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B) [Phase 1]
Phase 1 bioequivalence study comparing saxagliptin and metformin (Glucophage) combination formulations in healthy subjects; results were pos…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione [Phase 4]
Phase 4 trial comparing exenatide with sitagliptin on 24-hour average glucose in patients with Type 2 Diabetes Mellitus on metformin or a th…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245 (8245-004)(COMPLETED) [Phase 1]
This Phase 1 trial evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of MK8245 (8245-004) in individuals with Type 2…
-
CLINICAL_TRIALS research · 2011-01-17Clinical Trial Update: Efficacy and Safety Study of Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) to Treat Type 2 Diabetes Mellitus
Clinical trial update on the efficacy and safety of Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) for Type 2 diabetes mellitus with poor gly…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial comparing glimepiride and metformin as monotherapy in pediatric Type 2 Diabetes Mellitus has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating whether initiating insulin glargine (Lantus) earlier in the treatment of type 2 diabetes provides clinical benefits…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin [Phase 3]
This Phase 3 trial evaluated insulin glulisine given before meals versus after meals in adults with Type 2 Diabetes Mellitus receiving basal…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin [Phase 3]
Phase 3 trial evaluating insulin glulisine added to basal insulin glargine in adults with type 2 diabetes; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy [Phase 4]
A Phase 4 trial comparing adding insulin glargine versus rosiglitazone as add-on therapy in patients with Type 2 Diabetes Mellitus who faile…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial evaluating a Variable Bolus Regimen 1-2-3 for Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Insulin Glulisine in Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 clinical trial evaluating the safety and pharmacokinetics of insulin glulisine in individuals with Type 2 diabetes mellitus; the s…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Type 2 Diabetes Haptoglobin Phenotype and Vitamin E [Phase 2, Phase 3]
Completed Phase 2/Phase 3 trial investigating Vitamin E in patients with Type 2 diabetes mellitus, with analyses based on haptoglobin phenot…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Insulin Glargine in Type 2 Diabetes [Phase 4]
Sanofi-sponsored Phase 4 trial evaluating insulin glargine in Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin [Phase 4]
Phase 4 trial comparing insulin glargine (rDNA origin) injection to pioglitazone as add-on therapy in type 2 diabetes patients not adequatel…
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 study evaluating the combination of exenatide and insulin glargine in adults with Type 2 Diabetes Mellitus; results have been posted…
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients [Phase 1]
This Phase 1 trial update reports the completion of a study evaluating whether AZD1656 influences the pharmacokinetics of digoxin in patient…
-
CLINICAL_TRIALS research · 2011-01-04Clinical Trial Update: Laparoscopic Gastric Bypass for Type 2 Diabetes Mellitus With Body Mass Index (BMI) < 35 [NA]
Clinical trial update on laparoscopic gastric bypass for type 2 diabetes mellitus in patients with BMI under 35; status of the trial is curr…
-
CLINICAL_TRIALS trial_result · 2010-12-28Clinical Trial Update: Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care [Phase 3]
A Phase 3 trial evaluated acarbose for preventing or delaying progression to type 2 diabetes in people with impaired glucose homeostasis; th…
-
FDA approval · 2010-12-27FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN R (human insulin) submitted by Novo Nordisk.
-
FDA approval · 2010-12-22FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide. This action updates the regulatory status of the lir…
-
CLINICAL_TRIALS research · 2010-12-22Clinical Trial Update: Exercise Consultation for Type 2 Diabetes Patients in Real Life [NA]
This clinical trial entry describes a real-life exercise consultation study for adults with type 2 diabetes, with current status listed as u…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes [Phase 2]
Phase 2 safety study of TH9507 in adults with stable Type 2 diabetes has completed enrollment and safety assessment.
-
CLINICAL_TRIALS research · 2010-12-21Clinical Trial Update: Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus [NA]
A completed pilot clinical trial investigating the effects of resveratrol on endothelial function in adults with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035) [Phase 3]
Phase 3 sulfonylurea add-on study in Type 2 diabetes mellitus completed; results were posted in December 2010.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) [Phase 3]
A Phase 3 metformin add-on trial in patients with Type 2 diabetes mellitus has completed and its results have been posted.